Cargill’s profits more than doubled during its fiscal third quarter as it benefited from the recovering economy across all sectors, particularly in developing countries, the company has said.
After a host of positive moves over the past year, ChromaDex is optimistic about its future business, as it reported a 28 percent sales increase from $4.5m during fiscal 2008 to $5.7m in 2009.
Canadian natural and organics group SunOpta has reported a narrower loss in the fourth quarter of 2009, attributing improvement to restructuring and continued consumer interest in health and wellness.
Cognis has reported a 6.8 per cent decline in nutritional and health product revenue for the first 9 months of 2009 as the European market weakens and supplement sales slump.
Naturex president and chief executive officer, Jacques Dikansky, tells Shane Starling why in August the French botanicals giant bought Spanish supplier, Natraceutical Group, to double its size for the third time since 2002.
The economic recession is biting across the globe, and bleeding casualties litter all industries, but now is not the time to cower. Those willing to spend may provoke a stimulation of their business that could set them up for years, if not decades, to...
Supplements and healthy foods are proving to be more resilient than other sectors in the midst of the current economic freeze. Investment banker David Thibodeau tells Lorraine Heller why this sector will continue to perform.
Omega-3 supplier Martek Biosciences has reported a strong performance in the first quarter, indicating a growing interest in DHA despite the tight economy.
Cyanotech, which produces nutritional ingredients from microalgae, has said its focus on increased productivity and cost containment has helped reverse its loss from last year’s third quarter.
Swedish probiotics specialist, BioGaia, has turned in an impressive set of financial results for 2008, maintaining the 30 per cent-plus growth it has achieved annually for the best part of this decade.
Microalgae supplier Cyanotech said an increased productivity for spirulina and astaxanthin have helped lift its business out of loss in the second quarter.
Lipid Nutrition has signed an agreement to make ChemPoint the exclusive distributor of its weight management ingredients to the North American dietary supplement market.
DSM has turned in a healthy third quarter, with its nutrition division seemingly unaffected by the financial meltdown and demonstrating “sustained strong profitability”.
